Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Number of averted COVID-19 cases and deaths attributable to reduced risk in vaccinated individuals in Japan
Taishi Kayano, Misaki Sasanami, T. Kobayashi, et al.
The Lancet Regional Health - Western Pacific (2022) Vol. 28, pp. 100571-100571
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 19
Evaluating the COVID-19 vaccination program in Japan, 2021 using the counterfactual reproduction number
Taishi Kayano, Yura Ko, Kanako Otani, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Assessing the impact of Australia’s mass vaccination campaigns over the Delta and Omicron outbreaks
Lixin Lin, Haydar Demirhan, Simon P. Johnstone-Robertson, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0299844-e0299844
Open Access | Times Cited: 5
A counterfactual analysis quantifying the COVID-19 vaccination impact in Sweden
Fanny Bergström, Felix Günther, Tom Britton
Vaccine (2025) Vol. 52, pp. 126870-126870
Open Access
Key Essentials during the Transition from the Acute Phase of the COVID-19 Pandemic
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
(2023)
Open Access | Times Cited: 10
Predictive biomarkers of COVID-19 prognosis identified in Bangladesh patients and validated in Japanese cohorts
Kazuko Uno, A. R. Hasan, Emi E. Nakayama, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Cutaneous adverse events following COVID‐19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies
Atsunori Baba, Kiyoko Yamada, Takuro Kanekura
The Journal of Dermatology (2024) Vol. 51, Iss. 6, pp. 827-838
Closed Access | Times Cited: 2
Direct impact of COVID-19 vaccination in Chile: averted cases, hospitalizations, ICU admissions, and deaths
Antoine Brault, Andrew Hart, Paula Uribe, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Third doses of COVID-19 vaccines reduce infection and transmission of SARS-CoV-2 and could prevent future surges in some populations: a modeling study
Billy J. Gardner, A. Marm Kilpatrick
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 17
Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study
Wataru Mimura, Chieko Ishiguro, Junko Terada-Hirashima, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 6
Spread of SARS-CoV-2 Infection in Adult Populations in Cameroon: A Repeated Cross-Sectional Study Among Blood Donors in the Cities of Yaoundé and Douala
Arsène Brunelle Sandie, Françoise Ngo Sack, Christiane Ingrid Medi Sike, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 2, pp. 266-278
Open Access | Times Cited: 5
Changes in life expectancy and life span equality during the COVID-19 epidemic in Japan up to 2022
Yuta Okada, Hiroshi Nishiura
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Clinical Course and Factors Correlated with Severe Morbidity and Mortality in Patients with Coronavirus Disease 2019 Undergoing Maintenance Dialysis in Kanagawa, Japan
Kohei Ishiga, Hiromichi Wakui, Kengo Azushima, et al.
Internal Medicine (2024)
Open Access | Times Cited: 1
Estimating the number of severe COVID-19 cases and COVID-19-related deaths averted by a nationwide vaccination campaign in Republic of Korea
Ji Hae Hwang, Ju Hee Lee, Eun Jung Jang, et al.
Osong Public Health and Research Perspectives (2023) Vol. 14, Iss. 3, pp. 164-172
Open Access | Times Cited: 4
Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021–2022
Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, Ana Miqueleiz, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 58-58
Open Access | Times Cited: 1
Assessing the COVID-19 vaccination program during the Omicron variant (B.1.1.529) epidemic in early 2022, Tokyo
Taishi Kayano, Hiroshi Nishiura
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
The Nobel Prize in Physiology or Medicine 2023 was awarded for discoveries concerning base modifications that enabled the development of effective mRNA vaccines against COVID-19
Fukumi Furukawa
Trends in Immunotherapy (2024) Vol. 8, Iss. 1, pp. 3463-3463
Open Access
Causal Estimands for Analyses of Averted and Avertible Outcomes due to Infectious Disease Interventions
Katherine Min Jia, Christopher Boyer, Jacco Wallinga, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Science-based exit from stringent countermeasures against COVID-19: Mortality prediction using immune landscape between 2021 and 2022 in Japan
Taishi Kayano, Misaki Sasanami, Hiroshi Nishiura
Vaccine X (2024) Vol. 20, pp. 100547-100547
Open Access
Insights from a multicenter nationwide cohort analysis in Japan on the association of underlying conditions and pharmacological interventions with COVID-19 disease severity
Kyoka Sakamaki, Kiyoshi Shibuya, Wataru Ando
Deleted Journal (2024) Vol. 21, Iss. 1
Open Access
Evaluating the effectiveness of vaccination campaigns: Insights from Unvaccinated Mortality Data
Lixin Lin, Haydar Demirhan, Lewi Stone
Infectious Disease Modelling (2024) Vol. 10, Iss. 1, pp. 365-373
Open Access
Humoral anti-SARS-CoV-2 immune response for different strains after Sinovac-CoronaVac and Oxford/AstraZeneca (ChAdOx1-S) full vaccination on a healthcare population in Brazil
Maicon Jeferson Silva de Oliveira, Beatriz Birelli do Nascimento, Fernanda de Assis Oliveira, et al.
Revista Uningá (2024) Vol. 61, pp. eUJ4570-eUJ4570
Open Access
A counterfactual analysis quantifying the COVID-19 vaccination impact in Sweden
Fanny Bergström, Felix Günther, Tom Britton
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Impact of High Covid-19 Vaccination Rate in an Aging Population: Estimating Averted Hospitalizations and Deaths in the Basque Country, Spain Using Counterfactual Modeling
Carlo Delfin S. Estadilla, Javier Mar, Oliver Ibarrondo, et al.
Journal of Epidemiology and Global Health (2024) Vol. 14, Iss. 3, pp. 1289-1299
Open Access
Public funding and young children vaccination coverage: Evidence from Socialist-Oriented Market Economy
Tri-Duc Luong, Dao Van Le
Health Economics Review (2024) Vol. 14, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top